KirstenEllizabethLykeMD
Infectious Disease • Baltimore, MDAssociate Professor, Medicine, University of Maryland School of Medicine
Are you Dr. Lyke?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 88 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
22 S Greene St
Baltimore, MD 21201Phone+1 410-328-5793Fax+1 410-328-0248
Summary
- Dr. Kirsten Lyke, MD is an infectious disease specialist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland and Arizona. She is affiliated with Veterans Affairs Maryland Health Care System-Baltimore Division and University of Maryland Medical Center.
Education & Training
Johns Hopkins UniversityFellowship, Infectious Disease, 1998 - 2001
Duke University HospitalResidency, Internal Medicine, 1992 - 1995
Georgetown University School of MedicineClass of 1992
Certifications & Licensure
MD State Medical License 1998 - 2026
AZ State Medical License 1996 - 1999- American Board of Internal Medicine Infectious Disease
Clinical Trials
- PfSPZ Vaccine: Dose Optimization With Heterologous Challenge in Healthy Malaria-Naïve Adults Start of enrollment: 2016 Jan 01
- Combination HTNV and PUUV DNA Vaccine Start of enrollment: 2019 Oct 11
Publications & Presentations
PubMed
- Immune gene expression changes more during a malaria transmission season than between consecutive seasons.Kieran Tebben, Salif Yirampo, Drissa Coulibaly, Abdoulaye K Koné, Matthew B Laurens
Microbiology Spectrum. 2024-10-03 - Children with hemoglobin C or S trait have low serologic responses to a subset of malaria variant surface antigens.Rachel D Bailey, Jonathan G Lawton, Amadou Niangaly, Emily M Stucke, Jason A Bailey
The Journal of Infection. 2024-10-01 - 6 citationsEfficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial.Kirsten E Lyke, Joel V Chua, Michael Koren, Heather Friberg, Gregory D Gromowski
The Lancet. Infectious Diseases. 2024-08-01
Press Mentions
Building a Biomedical Research Enterprise That Leads to More Equity and Healthier LivesOctober 28th, 2024- Small Study Shows Promise for Antimalarial Monoclonal Antibody to Prevent MalariaJanuary 26th, 2023
- A Three-Dose Malaria Vaccine Shows Safety, Efficacy in West African AdultsDecember 22nd, 2022
- Join now to see all
Grant Support
- Immunologic Determinants Of Schistosoma-Mediated Resistance To Malaria In HumansNational Institute Of Allergy And Infectious Diseases2008–2011
- Immunologic Interaction Of Schistomiasis &Acute MalariaNational Institute Of Allergy And Infectious Diseases2002–2005
